Diabetes Risk Reduction and Metabolic Surgery

Abstract

Type 2 diabetes mellitus (T2D) and associated comorbid medical conditions are leading causes of strain on the American health care system. There has been a synchronous rise of obesity to epidemic proportions. If poorly treated, T2D is a scourge for patients, leading to end-organ damage and early mortality. Although T2D is considered best managed with lifestyle modification, medical management, and pharmacotherapy, recent studies have confirmed the superiority of metabolic surgery to conventional treatment algorithms as a path to remission. Increasing access to metabolic surgery will continue to yield benefits to patient health and improve the macroeconomic health of the world.

Keywords: Duodenal switch; Metabolic surgery; Roux-en-Y gastric bypass; Single-anastomosis duodeno-ileal bypass; Type 2 diabetes mellitus; Vertical sleeve gastrectomy.